A fertility pen, redesigned to incorporate updates and new features developed from patient and provider feedback, has been FDA approved and will be available December 2013.
There is no evidence that intracytoplasmic morphologically selected sperm injection (IMSI) provides subfertile patients an additional benefit over the standard intracytoplasmic sperm injection (ICSI).
Implantation rates in unstimulated IVF cycles compared favorably with those in stimulated IVF cycles in a retrospective analysis.
In October 2012, the American Society of Reproductive Medicine announced it no longer considers oocyte freezing experimental. This raises complex questions about how to counsel patients who wish to preserve eggs for social indications.
Uterine artery embolization for fibroids results in a tremendous reduction in menorrhagia. But while complication rates are low, up to 15% of patients are readmitted for indications like pain, bleeding and infection.
In patients with an American Fertility Society class V or class VI septate uterus, hysteroscopic metroplasty is associated with a significant improvement in reproductive performance.
This patient presented with 18 months of secondary infertility following a second trimester dilation and extraction.
Recombinant pigment epithelium-derived factor (rPEDF) proposed as a novel physiological treatment for ovarian hyperstimulation syndrome (OHSS).
For the long protocol of down regulation in in vitro fertilization (IVF) cycles, are depot and daily gonadotropin-releasing hormone agonists (GnRHa) equally effective?
Hysteroscopic removal of polyps in women with unexplained infertility may increase their chances of becoming pregnant, concludes an intervention review conducted by the Cochrane Menstrual Disorders and Subfertility Group.